共 50 条
[32]
Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
[J].
CLINICOECONOMICS AND OUTCOMES RESEARCH,
2025, 17
:199-215
[33]
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis
[J].
PATIENT PREFERENCE AND ADHERENCE,
2024, 18
:1163-1171
[38]
Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot study
[J].
PATIENT PREFERENCE AND ADHERENCE,
2017, 11
:995-999
[40]
Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides
[J].
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION,
2024, 11 (03)